Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf/ERK cascade and Akt signaling pathway
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference42 articles.
1. Preclinical studies with erlotinib (Tarceva);Akita;Semin. Oncol.,2003
2. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1);Aktas;Mol. Cell. Biol.,1997
3. Erlotinib in cancer treatment;Bareschino;Ann. Oncol.,2007
4. Oncogenic kinase signalling;Blume-Jensen;Nature,2001
5. Erlotinib-induced dermatologic side-effects;Bovenschen;Int. J. Dermatol.,2009
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19;Reviews in Medical Virology;2023-12-21
2. Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments;Frontiers in Immunology;2023-03-06
3. EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment;International Journal of Molecular Sciences;2022-06-10
4. Isovitexin Inhibits Ginkgolic Acids-Induced Inflammation Through Downregulating SHP2 Activation;Frontiers in Pharmacology;2021-08-11
5. Investigation of Biomarkers and Handling Strategy of Erlotinib-Induced Skin Rash in Rats;Biological and Pharmaceutical Bulletin;2021-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3